MedPath

Chronotropic Incompetence (CI) Diagnostic Algorithm in Heart Failure Patients

Not Applicable
Terminated
Conditions
Heart Failure
Registration Number
NCT02358603
Lead Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Brief Summary

This study is to collect human activity and electrocardiogram (ECG) data from heart failure (HF) patients to aid in the development of a novel chronotropic incompetence (CI) algorithm designed to diagnose CI in patients with HF.

Detailed Description

The Investigation of the Chronotropic Incompetence Diagnostic Algorithm in Heart Failure Patients (CI Algorithm Study) is an acute data collection study using market released actigraphy devices (wGT3X-BT) and holter devices (DR 180) to measure study subjects' daily activities and surface ECG data simultaneously. The data will be analyzed to develop an algorithm to diagnose CI in patients with HF.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
48
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Chronotropic Incompetence Index of Patients With Heart Failure DiseaseImplant through 6 months

Compare chronotropic incompetence index in patients with heart failure using an interventional diagnostic algorithm compared to standard of care diagnostics.

Chronotropic Index = \[achieved maximal HR-resting HR\]/\[age-predicted maximal HR-resting HR\]. Normal CI is \~ 1 with low CI considered \< 0.8

Measurement described as: Chronotropic index=HRR/metabolic reserve.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Ruijin Hospital Luwan Branch, Shanghai JiaoTong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Sixth People's Hospital Affiliated to Shanghai Jiaotong University

🇨🇳

Shanghai, Shanghai, China

Ruijin Hospital Luwan Branch, Shanghai JiaoTong University School of Medicine
🇨🇳Shanghai, Shanghai, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.